Lazanda (fentanyl) nasal spray has been approved by the U.S. Food and Drug Administration to treat breakthrough pain in adults with cancer who are already receiving opioid therapy. Lazanda is the first nasal spray containing the commonly prescribed opioid painkiller fentanyl, the company said in a news release. Lazanda is available in five European countries under the brand name PecFent. FRIDAY, July 1 (HealthDay News).
If you have concerns about pain or painkillers please discuss it with your doctor. Alternatively you can talk directly to one of our nurse counsellors on 6738 9333 or email: enquiry@canhope.org
